#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	220	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c4.ctg.1	837	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis.";AAC(2')-Ic
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	160	Erm_37_	540	540	100.0	Erm_37_.l6.c4.ctg.1	996	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.';Erm(37)
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	0	26	Mycobacterium_tuberculosis_16S_4	1537	93	100.0	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.1	206	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	0	26	Mycobacterium_tuberculosis_16S_4	1537	301	100.0	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.2	301	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	358	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l15.c4.ctg.1	1601	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	820	822	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	358	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l15.c4.ctg.1	1601	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1039	1041	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	161	163	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	176	178	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	272	274	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	452	454	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	926	928	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1022	1024	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1061	1063	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	428	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	1603	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1139	1141	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	528	10	Mycobacteroides_abscessus_16S_4	1504	75	97.37	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	226	0.0	0	.	n	.	0	C69T	SNP	69	69	C	213	213	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	270	blaC	924	924	100.0	blaC.l15.c4.ctg.1	1374	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.';blaC
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	314	efpA	1593	1593	100.0	efpA.l15.c4.ctg.1	1985	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'efpA is an MFS transporter found in Mycobacterium tuberculosis.';efpA
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	211	213	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	214	216	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	802	804	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1162	1164	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1249	1251	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1585	1587	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2698	2700	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	788	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3686	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	2938	2940	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	807	809	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	810	812	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	981	983	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	987	989	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1008	1010	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1008	1010	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1008	1010	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1008	1010	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1023	1025	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1047	1049	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1047	1049	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1074	1076	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1074	1076	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1080	1082	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1089	1091	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1092	1094	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1158	1160	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1161	1163	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1194	1196	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1215	1217	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1224	1226	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1230	1232	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1281	1283	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1287	1289	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1308	1310	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1308	1310	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1308	1310	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1308	1310	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1329	1331	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1428	1430	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1470	1472	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1485	1487	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1497	1499	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1503	1505	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1581	1583	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1581	1583	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1602	1604	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1611	1613	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2325	2327	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	2967	2969	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3090	3092	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	950	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3490	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3162	3164	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	R738Q	1	R738Q	NONSYN	2212	2214	CGG	2412	2414	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	939	941	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	951	953	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	960	962	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	1008	1010	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1053	1055	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1059	1061	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1062	1064	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1062	1064	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1086	1088	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1086	1088	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1089	1091	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1089	1091	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1098	1100	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1104	1106	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1107	1109	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1119	1121	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1122	1124	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1125	1127	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1128	1130	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1173	1175	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1176	1178	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1179	1181	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1380	1382	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1392	1394	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1671	1673	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1704	1706	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	872	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3687	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3141	3143	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	442	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1549	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	555	557	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	442	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1549	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1362	1364	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	245	247	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	266	268	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	287	289	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	329	331	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	335	337	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	368	370	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	467	469	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	584	586	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	698	700	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	719	721	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	728	730	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	899	901	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	923	925	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	962	964	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1148	1150	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1184	1186	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1196	1198	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1217	1219	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1277	1279	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1346	1348	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1370	1372	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	356	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1962	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1601	1603	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	239	241	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	299	301	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	299	301	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	308	310	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	308	310	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	308	310	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	326	328	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	326	328	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	347	349	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	452	454	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	629	631	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	629	631	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	638	640	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	638	640	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	392	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1913	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1439	1441	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	284	286	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	305	307	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	329	331	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	329	331	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	335	337	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	338	340	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	341	343	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	359	361	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	395	397	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	404	406	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	407	409	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	419	421	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	431	433	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	431	433	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	446	448	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	446	448	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	E92A	0	.	.	274	276	GAA	470	472	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:E92A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	545	547	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	566	568	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	575	577	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	596	598	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	608	610	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	611	613	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	638	640	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	686	688	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	743	745	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	743	745	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	758	760	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	758	760	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	206	gidB	675	675	99.85	gidB.l15.c4.ctg.1	1078	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	794	796	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	271	273	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	493	495	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2212	2214	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	430	432	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	448	450	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	472	474	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	472	474	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	475	477	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	475	477	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	475	477	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	478	480	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	478	480	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	481	483	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	490	492	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	490	492	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	490	492	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	490	492	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	490	492	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	490	492	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	540	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2825	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	514	516	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1247	1249	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	1727	1729	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	1841	1843	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	1841	1843	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	1844	1846	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	1844	1846	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	1847	1849	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	486	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2664	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	1847	1849	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	296	298	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	311	313	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	311	313	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	389	391	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	482	484	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	530	532	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	533	535	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	671	673	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	224	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1182	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	830	832	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	618	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2263	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	231	233	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	618	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2263	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1146	1148	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	618	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2263	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1725	1727	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	618	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2263	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1833	1835	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	27	384	iniB	1440	1440	100.0	iniB.l15.c4.ctg.1	2251	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	536	538	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	480	iniC	1482	1482	100.0	iniC.l15.c17.ctg.1	1908	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	448	450	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	480	iniC	1482	1482	100.0	iniC.l15.c17.ctg.1	1908	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	943	945	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	272	kasA	1251	1251	100.0	kasA.l15.c17.ctg.1	1432	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	288	290	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	272	kasA	1251	1251	100.0	kasA.l15.c17.ctg.1	1432	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	453	455	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	272	kasA	1251	1251	100.0	kasA.l15.c17.ctg.1	1432	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	897	899	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	272	kasA	1251	1251	100.0	kasA.l15.c17.ctg.1	1432	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1026	1028	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	272	kasA	1251	1251	100.0	kasA.l15.c17.ctg.1	1432	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1251	1253	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	272	kasA	1251	1251	100.0	kasA.l15.c17.ctg.1	1432	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1329	1331	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1602	1604	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	312	314	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	486	488	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	543	545	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	546	548	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	588	590	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	591	593	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	594	596	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	639	641	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	654	656	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1005	1007	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1149	1151	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1158	1160	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1158	1160	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1158	1160	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1464	1466	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1596	1598	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1683	1685	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1737	1739	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2034	2036	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	622	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2621	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2193	2195	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	244	mfpA	552	552	100.0	mfpA.l15.c17.ctg.1	812	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.';mfpA
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	240	mshA_1	1443	1443	100.0	mshA_1.l6.c4.ctg.1	1784	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1215	1217	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	376	murA_4	1257	1257	100.0	murA_4.l15.c4.ctg.1	1547	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	503	505	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	231	233	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	237	239	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	240	242	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	243	245	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	249	251	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	249	251	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	249	251	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	252	254	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	255	257	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	255	257	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	258	260	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	258	260	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	258	260	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	264	266	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	264	266	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	264	266	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	270	272	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	270	272	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	279	281	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	279	281	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	285	287	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	297	299	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	306	308	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	309	311	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	330	332	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	351	353	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	363	365	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	366	368	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	366	368	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	369	371	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	369	371	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	369	371	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	375	377	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	375	377	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	381	383	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	381	383	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	387	389	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	390	392	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	390	392	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	399	401	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	399	401	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	402	404	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	414	416	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	426	428	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	429	431	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	432	434	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	432	434	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	432	434	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	432	434	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	432	434	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	435	437	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	441	443	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	444	446	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	444	446	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	456	458	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	456	458	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	462	464	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	474	476	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	483	485	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	483	485	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	498	500	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	510	512	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	516	518	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	516	518	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	516	518	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	516	518	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	519	521	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	528	530	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	534	536	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	534	536	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	537	539	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	537	539	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	540	542	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	576	578	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	582	584	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	585	587	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	591	593	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	603	605	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	624	626	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	627	629	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	630	632	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	633	635	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	636	638	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	636	638	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	636	638	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	639	641	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	639	641	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	642	644	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	642	644	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	642	644	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	645	647	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	645	647	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	645	647	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	648	650	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	651	653	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	654	656	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	654	656	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	666	668	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	690	692	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	693	695	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	699	701	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	705	707	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	708	710	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	711	713	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	711	713	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	720	722	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	732	734	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	741	743	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	741	743	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	741	743	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	744	746	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	744	746	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	750	752	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	753	755	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	768	770	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	222	pncA	561	561	99.82	pncA.l6.c4.ctg.1	900	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	774	776	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	250	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1141	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	153	155	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	590	592	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1502	1504	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1667	1669	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1676	1678	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1676	1678	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1676	1678	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1676	1678	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1676	1678	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1685	1687	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1700	1702	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	622	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	3966	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1730	1732	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	444	446	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1047	1049	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1050	1052	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1098	1100	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1101	1103	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1104	1106	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1107	1109	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	366	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1738	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1128	1130	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	120	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	717	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	294	296	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	120	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	717	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	303	305	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	120	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	717	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	438	440	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	120	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	717	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	438	440	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	16	18	rrsB_13	1528	77	100.0	rrsB_13.l15.c4.ctg.1	206	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	227	229	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	269	271	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	386	388	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	392	394	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	410	412	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	434	436	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	464	466	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	476	478	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	539	541	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	617	619	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	644	646	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	767	769	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	782	784	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	833	835	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	250	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1151	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	866	868	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	247	249	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	406	408	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	412	414	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	478	480	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	559	561	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	589	591	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	655	657	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	754	756	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	760	762	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	913	915	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	270	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1254	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	919	921	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
